Corvalol K Soft Capsules, No. 30 (10 x 3)
Composition
Active ingredients: ethyl ester of α-bromovaleric acid, menthol solution in menthyl ester of isovaleric acid, peppermint oil, hop oil;
1 capsule contains 16.63 mg of ethyl ester of α-bromoisovaleric acid, 45.74 mg of menthol solution in menthyl ester of isovaleric acid, 0.17 mg of hop oil, and 1.18 mg of peppermint oil;
excipients: sunflower oil, sucralose, glycerol monostearate, colloidal anhydrous silicon dioxide;
capsule shell composition: gelatin, glycerin, liquid maltitol, microcrystalline cellulose, guar gum, potato starch, xylitol, lemon flavoring, purified water.
Dosage Form
Soft capsules.
Main physical and chemical properties: oval-shaped soft gelatin capsules ranging in color from light yellow to light brown. The capsule contents are an oily suspension with a characteristic odor.
Pharmacotherapeutic group
Hypnotics and sedatives. Combinations of hypnotics and sedatives, excluding barbiturates. ATC code N05C X.
Pharmacological Properties
Pharmacodynamics.
Corvalol® K is a sedative and antispasmodic agent; its action as a combination drug is determined by its constituent components.
The ethyl ester of α-bromizovaleric acid exerts a reflex sedative and antispasmodic effect, resulting from irritation primarily of receptors in the oral cavity and nasopharynx, a decrease in reflex excitability in the central nervous system, increased inhibition in the neurons of the cerebral cortex and subcortical structures of the brain, as well as a reduction in the activity of the central vasomotor centers and a direct local antispasmodic effect on the smooth muscles of blood vessels.
Validol, or a solution of menthol in menthyl isovalerate, has a sedative effect as well as a moderate coronary vasodilatory effect due to its action on the sensitive nerve receptors of the oral mucosa.
Peppermint oil contains essential oils, approximately 50% menthol, and 4–9% menthol esters. These compounds stimulate the “cold” receptors in the oral cavity, causing a reflex dilation of the blood vessels in the heart and brain, and producing a calming and mild cholagogue effect. Peppermint oil has antiseptic and antispasmodic effects and helps relieve flatulence. By stimulating the receptors in the mucous membranes of the stomach and intestines, it enhances intestinal peristalsis.
Hop oil has a reflex vasodilatory and antispasmodic effect and relieves flatulence.
Pharmacokinetics.
When taken sublingually, absorption of the drug begins in the oral mucosa. The effect develops within 5 minutes and lasts for 3–6 hours.
Indications
- Neuroses with increased irritability;
- as part of complex therapy for hypertension and vegetative-vascular dystonia;
- mild coronary artery spasms and tachycardia;
- intestinal spasms.
Contraindications
- Hypersensitivity to any component of the drug;
- severe hypotension;
- acute myocardial infarction.
Interactions with Other Medications and Other Types of Interactions
Corvalol® K potentiates the sedative effects of psychotropic drugs, opioid analgesics, alcohol, and anesthetics when used concomitantly.
The effects of antihypertensive drugs may be potentiated when used concomitantly with Corvalol® K.
Corvalol® K reduces headaches caused by the use of nitrates.
Special Instructions for Use
If chest pain persists after taking the medication, it is essential to consult a doctor to rule out acute coronary syndrome.
Long-term use is not recommended due to the risk of bromine accumulation in the body and the development of bromine poisoning.
Use During Pregnancy or Breastfeeding.
Use of the drug during pregnancy or breastfeeding is possible if, in the doctor’s opinion, the expected benefit to the mother outweighs the potential risk to the fetus or infant.
Effect on reaction time when driving or operating machinery.
Side effects (dizziness and drowsiness) may occur in the first few hours after administration. Therefore, caution should be exercised by individuals who operate complex machinery or drive motor vehicles while taking this medication.
Dosage and Administration
Corvalol® K capsules are taken sublingually. Hold the capsule under the tongue until it is completely dissolved. To speed up the effect, the capsule may be crushed with the teeth.
Take 1 capsule 2–3 times daily, regardless of meals. If necessary (in cases of severe tachycardia or coronary vasospasm), the single dose may be increased to 2 capsules.
The duration of treatment is determined by the doctor based on the clinical response and tolerability of the medication.
Children.
There is no experience with the use of this medication in children.
Overdose
Prolonged use is not recommended due to the potential accumulation of bromine in the body and the risk of bromine poisoning.
Symptoms: headache, nausea, agitation, cardiac dysfunction, central nervous system depression, and decreased blood pressure.
Treatment: discontinuation of the drug and symptomatic treatment.
Side Effects
Corvalol® K is generally well tolerated. In rare cases, the following side effects may occur:
nervous system: drowsiness, dizziness, impaired concentration;
Gastrointestinal system: abdominal discomfort, mild nausea;
Immune system: development of allergic reactions, including angioedema, hives, rash, itching;
Other: transient hypotension, watery eyes.
Long-term use of bromine-containing medications may lead to bromine poisoning, which is characterized by the following symptoms: central nervous system depression, depressed mood, apathy, confusion, ataxia, purpura, rhinitis, conjunctivitis, acne. These symptoms resolve upon dose reduction or discontinuation of the medication.
Shelf life
1 year and 6 months.
Do not use the medication after the expiration date indicated on the package
Storage Conditions
Store in the original packaging at a temperature not exceeding 25 °C. Keep out of the reach of children.
Packaging
10 capsules per blister pack. 1 or 3 blister packs per package.
Dispensing Category
Over-the-counter.
Manufacturer
Farmak JSC.
Similar products
Products from the same category










